https://www.selleckchem.com/pr....oducts/emricasan-idn
Aeruginosa, respectively, with fractional inhibitory concentration indices of ≤0.5. None of the tested isolates exhibited antagonism. Our results showed that combinations of colistin and meropenem are associated with improvement in minimum inhibitory concentration and may be a promising strategy in treating meropenem-resistant A. baumannii respiratory tract infections. Our results showed that combinations of colistin and meropenem are associated with improvement in minimum inhibitory concentration and may be a pro